Word count abstract: 250 25 Word count importance: 142 26 Word count text: 6.144 Abstract 29 Human cytomegalovirus (HCMV) envelope glycoprotein complexes, gH/gL/gO-trimer and 30 gH/gL/UL128L-pentamer, are important for cell-free HCMV entry. While soluble Nrp2-Fc 31 (sNrp2-Fc) interferes with epithelial/endothelial cell entry through UL128, soluble PDGFRα-32
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). Mutant gO GT3 and the two recombinant forms, GT1c/GT3 and GT3/GT1c, along 144 with gO GT4 displayed a significantly higher epithelial cell infectivity compared to gO GT1c. 145 In summary, the data show that gO GT swapping, either full-length or partial, does not impair 146 the capacity to infect fibroblasts but seems to affect epithelial cell tropism.
148
Content of gO and gH in the envelope of gO GT mutant viruses 149 Cell-free virions of parental strain TB40-BAC4-luc are characterized by high gO abundance 150 and low UL128 expression. This is thought to result in a high trimer-to-pentamer ratio 151 associated with a low efficiency for epithelial cell infection (12) . Thus, we wanted to know 152 whether the enhanced epithelial cell infectivity of gO GT3, gO GT1c/GT3 and gO GT3/GT1c 153 results from changes in the trimer-to-pentamer ratio upon gO GT swapping. To this end, 154 parental and mutant virions were purified from fibroblast supernatant and the amounts of gO 155 and gH were determined by semi-quantitative western blot under reducing conditions. The total 156 amount of virions was normalized to gB and/or major capsid protein (MCP). The gO content 157 represents the amount of trimer and the gH level is assumed to indicate the overall amount of 158 trimer and pentamer in virions. One representative immunoblot for each mutant is given in 159 Figure 3 , and the estimated virions' gO and gH contents are shown in Table 1 . In comparison 160 to gO GT1c the amount of virions' gO was severely reduced in gO GT3 (~ 80%), GT3/1c (~ 161 90%), GT1c/3 (~ 50%), a subtle reduction was found for gO GT5 (~ 30%), but no substantial 162 changes for gO GT4 mutant virions. Notably, almost no gO was detectable in gO GT2b virions 163 even when very high virion concentrations were used for immunoblotting (see Supplementary   164 Figure 2). Although it cannot be excluded that gO GT2b virions harbour very low levels of gO 165 it is more likely that the anti-gO antibody used in this study which is directed towards gO GT1c 166 of TB40E (32) does not cross-react with gO GT2b while the gO genotypic forms GT3, GT4, 167 and GT5 are well recognized (see Supplementary Figure 2 ). With regard to the gH content it 168 appears that the mutant virions GT3 and GT1c/GT3 harbour 1.6 to 3.2 fold higher gH levels whereas GT2b, GT4, and GT5 contain moderately lower levels as compared to gO GT1c. 175 Since all gO GT mutants retained the ability to infect fibroblasts and epithelial cells, we were 176 able to directly compare the inhibitory capacity of sPDGFRα-Fc between the five major gO 177 genotypic and the two recombinant forms. The inhibition experiments were performed with a 178 fixed amount of infectious viruses pre-incubated for 2 hours with a 2-fold dilution series of 179 sPDGFRα-Fc ranging from 0.0025 to 0.625 µg/ml. After another 2 hour-incubation on 180 fibroblasts or epithelial cells, respectively, cells were washed and subsequently incubated with 181 fresh medium for further 2 days. RLUs were monitored by a luciferase assay and plotted against 182 the concentration of sPDGFRα-Fc.
Inhibition of cell-free fibroblast and epithelial cell infectivity by soluble PDGFRα-Fc

183
First, the appropriate amount of infectious input virus was determined using three different 184 virus dilutions of parental strain gO GT1c. As shown in Figure 4A and 4B there was no 185 substantial change in the overall shape of the dose-dependent inhibition over a wide range of 186 input infectivity. Thus, for all further inhibition experiments the cell-free virus stocks were 187 normalized to similar RLUs within the tested range (see Materials and Methods). In all mutants, 188 cell-free infectivity was inhibited by sPDGFRα-Fc in a dose-dependent manner. One 189 representative curve for gO GT1c and the gO GT mutants is shown in Figure 4C and 4D. The 190 half-maximal inhibition (IC50) as calculated by non-linear regression ranged from 49 ng/ml to 191 73 ng/ml for fibroblasts and from 24 ng/ml to 56 ng/ml for epithelial cells (see Table 2 ). None 192 of the mutants' IC50 value significantly differed from IC50 of parental strain. Moreover, there 193 was no difference between parental strain and mutants in the overall steep shape of the dose-194 response curves (slopes >1), neither in fibroblasts nor in epithelial cells, except for one of the recombinant mutants, gO GT1c/3, in epithelial cells. This gO mutant showed a shallower dose-196 response curve with a slope of 1.0 to 2.6 (see Table 2 ). The slope parameter mathematically 197 analogous to the Hill coefficient is a measure of cooperativity (33) in the binding of multiple 198 ligands (e.g. sPDGFRα-Fc) to linked binding sites (e.g. gO). Dose-response curves with a slope 199 of about 1.0 are indicative for non-cooperativity which means the ligand binds at each site 200 independently. In contrast, steep curves with slopes much larger than 1.0 are thought to result 201 from a form of positive cooperative effects upon ligand binding (33). Hence, these findings 202 suggest that the presumed positive cooperativity is weakened when sPDGFRα-Fc binds to gO 203 GT1c/3.
204
Next, we determined the maximal extent of inhibition at 1.25 µg/ml sPDGFRα-Fc calculated 205 as 1 -(RLU after pretreatment / RLU of untreated virus stocks). The inhibition of fibroblast 206 infectivity was almost complete (> 99%) and did not differ between gO GT1c and mutants (see 207 Figure 4E ). In epithelial cells, in contrast, one of the recombinant mutants, gO GT1c/3, retained 208 a significantly higher infectivity (mean: 9%) at this inhibitor concentration compared to gO 209 GT1c. The other mutants did not differ from the parental strain. The reduced epithelial cell 210 inhibition of gO GT1c/3 by sPDGFRα-Fc is well in accordance with the shallower shape of the 211 dose-response curve ( Figure 4D ). Notably, the inhibition efficiency was slightly less effective 212 in epithelial cells (~ 98 -99%) than in fibroblasts for gO GT1c and the mutants, GT2b, GT3, 213 and GT3/1c (see Figure 4E ).
214
In summary, these findings show that not only the five major genotypic forms of gO are 215 recognized by sPDGFRα-Fc but also recombinant forms of gO. Albeit, one recombinant version 216 of gO seems to be less effectively inhibited by sPDGFRα-Fc on epithelial cells. 
Inhibition of cell-free fibroblast and epithelial cell infectivity by soluble NRP2-Fc
219
It has recently been reported that soluble forms of NRP2 which specifically bind to UL128, 220 inhibit epithelial cell infection while fibroblast infection remains largely unaffected (29). We wanted to know whether alterations in the virions' gO and gH content upon gO GT swapping 222 may indirectly affect the inhibitory capacity of sNRP2-Fc. To address this question, first we 223 performed inhibition experiments on epithelial cells using a 2-fold dilution series of sNRP2-Fc 224 (range: 0.0025 to 0.626 µg/ml) and a fixed amount of RLU-normalized gO GT virions as 225 described for sPDGFRα-Fc. Two independent experiments were performed for each mutant 226 along with the parental strain and one representative curve is shown in Figure 5A . The dose-227 dependent inhibition was similar between parental strain and gO GT mutants, the dose-response 228 curves displayed slopes of about 1.0 (range: 0.7 to 2.1) and the IC50 values ranged from 31 to 229 90 ng/ml (see Table 2 ). These findings indicate that neither the gO genotypic form nor changes 230 in the virion's gO content influences the capacity of sNRP2-Fc for epithelial cell inhibition.
231
Finally, we wanted to assess the maximum inhibitory capacity of 1.25 µg/ml sNRP2-Fc on 232 epithelial cells and whether such high inhibitor concentrations also have an effect on fibroblast 233 infectivity. As shown in Figure 5B , epithelial cell infectivity was 96% to 98% reduced in all 234 mutant viruses and this did not significantly differ between parental strain and mutants. gO gene sequences in the otherwise identical TB40-BAC4-luc background, tested the set of gO mutants for their capability to infect fibroblasts and epithelial cells, for their relative 249 composition of gO and gH in cell-free virions, and evaluated the inhibitory capacity of 250 sPDGFRα-Fc in comparison to sNRP2 inhibition.
251
First, we demonstrate that gO GT swapping, either partial or full-length, does not substantially 252 affect fibroblast infectivity but may lead to an increase in relative epithelial cell infectivity. In 253 particular, the mutants gO GT3, GT3/1c, and GT1c/3, which displayed the strongest 254 enhancement in epithelial cell infection, contained substantially lower gO but higher gH levels 255 in their cell-free virions as compared to parental strain. Previous studies have revealed that gO 256 and UL128 compete for binding to the same gL cysteine residue in gH/gL (7) which in turn 257 regulates the trimer to pentamer ratio (7, 8) and this renders virions more infectious for 258 fibroblasts (high trimer to pentamer ratio) or epithelial cells (low trimer to pentamer ratio) (11, 259 12). Since parental strain TB40-BAC4-luc is characterized by vastly more gO than UL128 260 accompanied by a low epithelial cell infectivity (12) it is likely that the opposite changes in gO 261 and gH levels upon partial or full-length GT3 swapping cause a shift towards lower trimer to 262 pentamer ratio which may well explain the increase in epithelial cell infectivity. The impact of 263 the relative composition of gO and gH in terms of epithelial cell infectivity is further underlined 264 by the observation that replacement of gO GT1c by GT5 which causes a subtle reduction in 265 both, gO and gH, has no effect on epithelial cell infectivity. Similarly as recently reported, gO 266 GT1b to GT5 swapping and vice versa has also no effect on gO expression levels (13).
267
Together, these findings suggest that the relative abundance of gO and gH incorporated into 268 cell-free virions is influenced by the gO genotypic form. Recently, UL148 has been identified 269 to regulate the trimer to pentamer ratio by stabilizing gO within the endoplasmatic reticulum 270 (34, 35) . It is tempting to speculate that the regulatory capability of UL148 is influenced by the 271 gO sequence. Additionally, it cannot be excluded that GT sequence-specific characteristics 272 directly modify the capacity of cell-free virions for entry into epithelial cells, since gO GT4 displayed an enhanced epithelial cell tropism without substantial alterations in gO and gH 274 abundance, as previously shown (23). 275 Remarkably, despite significant differences in epithelial cell tropism, the fibroblast infectivity 276 was similar among the mutants and parental strain. These findings indicate that neither changes 277 in gO and gH abundance nor gO GT sequence-specific characteristics affect the capacity for 278 fibroblast infection. Moreover, these data lead to the conclusion that all of these gO genotypic 279 forms can bind to the cellular fibroblast receptor PDGFRα with similar efficiency. Strikingly, 280 a minimum level of gO on cell-free virions seems to be still sufficient for normal fibroblast 281 infection under the tested in vitro conditions as in particular gO GT3 and gO GT1c/3 mutants 282 display very low gO levels. Taken together, these observations provide clear evidence that gO 283 polymorphism has a substantial impact on epithelial cell but not on fibroblast infectivity.
284
Further investigations will clarify how differences in the gO and gH abundance and/or GT-285 specific sequence characteristics affect epithelial cell entry of cell-free virions.
286
Recombination among different HCMV strains appears to be a major driving force in HCMV 287 evolution as shown by numerous studies (36). Recently, the recombination density throughout 288 the genome was deeply investigated by whole genome sequence comparisons exploring past 289 and recent recombination events as well (16, 20, 21) . A particularly interesting finding was the 290 identification of pervasive genome-wide recombination generating diversity both within and 291 between genes (16, 21). So far, little is known about potential functional consequences for 292 individual genes upon intragenic recombination. In the present study, we have now included 293 two chimeric gO GT mutants, each of them carrying a recombinant gO genotypic form 294 composed of GT1c and GT3 sequences. One of them, gO GT3/1c, harbours the recombination 295 breakpoint within the conserved C-terminal part of gO and this mutant differs from full-length 296 gO GT3 in only 4 amino acid residues. The recombination breakpoint of the other one, gO 297 GT1c/3, is located in a small identical sequence stretch between GT1c and GT3 in the otherwise 298 highly polymorphic N-terminal part of gO. Recombination resulted in a severely altered gO sequence with an amino acid diversity of 9% from GT1c and of 10% from GT3. Strikingly, 300 both recombinant gO mutants not only fully retained the ability to infect fibroblasts they even 301 displayed an enhancement in epithelial cell infectivity comparable to full-length GT3 mutant.
302
As discussed above, the change in gO and gH abundance may cause the observed epithelial cell 303 phenotype. Accordingly, these findings indicate that recombination within the gO gene could 304 be considered as an important function for HCMV to generate (i) gene diversity with or without 305 modified functions and (ii) novel combinations of neighbouring loci even when they are highly 306 diverse. This is well in concordance with previously reported sequencing data showing that 307 recombination within gO may sporadically occur also in vivo despite a strong linkage between 308 gO and the adjacent, partly overlapping gN gene (16, 17, 21, 22, 37) .
309
Recent studies have shown that PDGFRα specifically interacts with the gO subunit of the trimer 310 which is required for entry into fibroblasts (25-28). As soluble forms of PDGFRα or derivatives 311 thereof can inhibit cell-free infection of several cell types (26) it appears that binding of 312 sPDGFRα to gO interferes with trimer-mediated function(s) widely required for cell entry. We (27). Thus, it is tempting to speculate 320 that a trimer-independent entry mechanism accounts for the residual infectivity. Alternatively, 321 it is also possible that not all virions are neutralized at this concentration allowing for a residual 322 infection.
323
Remarkably, one of the two recombinant mutants, gO GT1c/GT3, displayed a significantly 324 lower sensitivity for sPDGFRα inhibition on epithelial cells than the other mutants while the fibroblast inhibition was similarly effective. As mentioned above this mutant comprises its 326 recombination site in the highly polymorphic N-terminal region of the protein, which only 327 recently was suggested to contain the PDGFRα receptor binding domain (31). By mutational 328 analysis the authors identified a small stretch from amino acid 117 to 121 causing the strongest 329 impairment of sPDGFRα binding to virus particles and consequently also a reduced virus 330 penetration into fibroblasts. Although this peptide site overlaps with the recombination site of 331 GT1c/GT3, the specific sequence remained unchanged upon recombination suggesting that 332 sPDGFRα binding to this recombinant form of gO is not impaired. This presumption fits well 333 to the finding that gO GT1c/GT3 mutant does not display a phenotype in fibroblast infectivity 334 while mutants with a mutation in this particular peptide sequence showed reduced penetration 335 into fibroblasts (31). Hence, we assume that the impaired sPDGFRα inhibition for gO 336 GT1c/GT3 mutant on epithelial cells is not caused by a lower binding of sPDGFRα to gO but 337 rather by an impaired interference with a downstream entry step mediated by the trimer.
338
The assumption that binding of sPDGFRα to gO-trimer affects more entry properties than the 339 unique block of the receptor binding site is further strengthened by our findings that inhibition Thus, it is presumable that binding of high amounts of sNRP2 to virions lead to steric hindrance 370 of the trimer which becomes visible only for virions with low gO levels.
371
In conclusion, in this study we show that the trimer to pentamer ratio which is substantially 372 affected by gO polymorphism has no influence on the inhibitory capacity of sPDGFRα but may 373 render virions slightly susceptible to sNRP2 inhibition on fibroblasts. When sPDGFRα or 374 derivates thereof are considered for a therapeutic option to HCMV infection it should be taken 375 into account that gO intragenic recombination may lead to partial evasion from sPDGFRα 376 inhibition.
Human foreskin fibroblasts (HFFs) were cultured in minimum essential medium Eagle (MEM; within US17 (forward primer GCGTGCTTTTTAGCCTCTGCA (10 pM), the reverse primer 457 AAAAGTTTGTGCCCCAACGGTA (10 pM), TaqMan probe FAM-TGATCGGCGTTATCG 458 CGTTCTTGATC-TAMRA (2 pM)) as previously described (23). were compared to gB. Contents of gO and gH were compared between gO GT1c and the respective gO 820 mutants. For each mutant an additional 2-fold dilution was loaded on the gel. Band densities were 821 determined relative to the GT1c reference band for each blot individually, and are shown below the 822 blots. 823 .|....|....|....|....|....|....|....|....|....|....|....|....|....|....|. ...| 
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